| Petrides, Georgios |
NCT03926520: Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD) |
|
|
| Recruiting | N/A | 50 | US | Electroconvulsive Therapy (ECT) | Brent Forester, Mayo Clinic, Pine Rest Christian Mental Health Services, Emory University, The Zucker Hillside Hospital, Medical University of South Carolina | Alzheimer Dementia, Agitation,Psychomotor | 05/25 | 05/25 | | |
| Malhotra, Anil K |
ModSoCCS, NCT04418011: Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders |
|
|
| Completed | N/A | 70 | Canada, US | Repetitive Transcranial Magnetic Stimulation, Repetitive Transcranial Magnetic Stimulation (Intermittent Theta Burst Stimulation), Repetitive Transcranial Magnetic Stimulation (Sham) | Centre for Addiction and Mental Health, The Feinstein Institutes for Medical Research, University of Maryland School of Medicine, National Institutes of Health (NIH) | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders | 02/23 | 02/23 | | |
NCT02822092: Striatal Connectivity and Clinical Outcome in Psychosis |
|
|
| Completed | N/A | 196 | US | Risperidone or Aripiprazole (patients only), Risperidal, Aripiprazole | Northwell Health, National Institutes of Health (NIH) | Psychotic Disorders | 12/23 | 12/23 | | |
| Kane, John |
NCT06179108: Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia |
|
|
| Active, not recruiting | 2 | 350 | US | LB-102 | LB Pharmaceuticals Inc. | Schizophrenia | 12/24 | 05/25 | | |
NCT00900198: Collection of Tissue Samples for Cancer Research |
|
|
| Recruiting | N/A | 5000 | Canada, US | Biopsy | National Cancer Institute (NCI) | Neoplasms, Lymphomas, Multiple Myeloma, Myelodysplastic Syndrome | | | | |
| Braga, Raphael J |
ENLIGHTEN, NCT05113771: A Biomarker-Guided, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With Treatment-Resistant Depression |
|
|
| Completed | 2 | 197 | Canada, US | Liafensine, Placebo | Denovo Biopharma LLC | Treatment Resistant Depression | 02/24 | 03/24 | | |
| Zhang, Jianping |
NCT06552520: To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis |
|
|
| Not yet recruiting | 3 | 500 | RoW | TQH2722 injection, Placebo of TQH2722 injection | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | Atopic Dermatitis | 10/25 | 06/26 | | |
NCT06775860: ICP-332 in Subjects with Moderate to Severe Atopic Dermatitis |
|
|
| Recruiting | 3 | 552 | RoW | ICP-332 Tablets, ICP-332 Placebo Tablets | Beijing InnoCare Pharma Tech Co., Ltd. | Atopic Dermatitis | 11/26 | 12/26 | | |
NCT06631170: Efficacy and Safety of Roflumilast Cream in Subjects with Atopic Dermatitis |
|
|
| Recruiting | 3 | 351 | RoW | Roflumilast Cream 0.15%, Vehicle cream | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Atopic Dermatitis (AD) | 08/25 | 08/25 | | |
NCT06109818: Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis |
|
|
| Recruiting | 2 | 129 | RoW | ICP-488 Tablets, ICP-488 Placebo | Beijing InnoCare Pharma Tech Co., Ltd. | Moderate to Severe Plaque Psoriasis | 10/24 | 11/24 | | |
| Ben-Zeev, r |
NCT04147897: Implementing mHealth for Schizophrenia in Community Mental Health Settings |
|
|
| Active, not recruiting | N/A | 303 | US | FOCUS | University of Washington, National Institute of Mental Health (NIMH) | Schizophrenia | 09/24 | 11/24 | | |
NCT05703711: Combining mHealth and Nurse-delivered Care to Improve the Outcomes of People With Serious Mental Illness in West Africa |
|
|
| Recruiting | N/A | 360 | RoW | mHealer | University of Washington, National Institute of Mental Health (NIMH) | Psychosis, Mania, Depression | 05/27 | 05/27 | | |
| Argyelan, Miklos |
| Recruiting | 1 | 20 | US | Medtronic SenSight Directional DBS lead | Northwell Health, Medtronic | Treatment Resistant Depression | 10/30 | 10/38 | | |
NCT04763655: Neural Biomarkers of Electroconvulsive Therapy Response |
|
|
| Recruiting | N/A | 75 | US | clinical and neuropsychological testing, MRI of the brain | Northwell Health, National Institutes of Health (NIH) | Electroconvulsive Therapy Treated Patients | 12/24 | 07/25 | | |
| Recruiting | N/A | 50 | US | Reclaim™ DBS Therapy | Northwell Health, Medtronic | Obsessive-Compulsive Disorder (OCD) | 01/30 | 01/30 | | |
| Joanlanne, Andrea |
ModSoCCS, NCT04418011: Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders |
|
|
| Completed | N/A | 70 | Canada, US | Repetitive Transcranial Magnetic Stimulation, Repetitive Transcranial Magnetic Stimulation (Intermittent Theta Burst Stimulation), Repetitive Transcranial Magnetic Stimulation (Sham) | Centre for Addiction and Mental Health, The Feinstein Institutes for Medical Research, University of Maryland School of Medicine, National Institutes of Health (NIH) | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders | 02/23 | 02/23 | | |
| Recruiting | N/A | 100 | US | iTBS (Active), iTBS (Sham) | Northwell Health, Wellcome Trust, Centre for Addiction and Mental Health, University of Maryland, Baltimore | Schizophrenia, Schizo Affective Disorder, Schizophreniform Disorders, Psychosis Nos/Other | 04/27 | 04/27 | | |
| Tang, Sunny X |
| Completed | N/A | 77 | US | There is no intervention | Northwell Health, Winterlight Labs | Schizophrenia and Related Disorders | 03/23 | 03/23 | | |
NST-SPARK-1b, NCT06653829: NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia |
|
|
| Completed | N/A | 20 | US | SPARK | North Shore Therapeutics, Inc. | Negative Symptoms in Schizophrenia, Schizophrenia, Schizoaffective Disorder | 08/24 | 08/24 | | |
